CDMOs

CDMOs

featured image of Novo Holdings Invests $165bn in CDMO Catalent Fueling Biotech Growth

Novo Holdings Invests $165bn in CDMO Catalent Fueling Biotech Growth

BIOT

🔍 Novo Holdings buys CDMO Catalent for $16.5bn, aiming to support its expansion in the CDMO market. 🏢💼📈

featured image of Game-Changing Merger Creates European CDMO Powerhouse

Game-Changing Merger Creates European CDMO Powerhouse

BIOT

🔍 Biovian and 3P Biopharmaceuticals merge to create 3PBIOVIAN, a European CDMO offering end-to-end services. 🌍👥🔬🧫🧬💪

featured image of Revolutionary Startup Aims to Transform Cell and Gene Therapies

Revolutionary Startup Aims to Transform Cell and Gene Therapies

BIOT

📰 Frustration with CDMOs fuels ambition for advanced therapy startup GDMC, offering end-to-end solutions for cell and gene therapies. 💡💪🌱🧬

featured image of Celltrion's Game-Changing 5-Year Partnership Boosts Biotech

Celltrion’s Game-Changing 5-Year Partnership Boosts Biotech

BIOT

📢 Celltrion taps Prestige Bio in a 5-year CDMO deal, expanding its capabilities and strengthening its global position. 💼🌐💪📈

featured image of Pluri Revolutionizes Cell Therapy with Expanded CDMO Services

Pluri Revolutionizes Cell Therapy with Expanded CDMO Services

BIOT

🌟 Pluri, a cell therapy pioneer, ventures into the CDMO space, offering end-to-end services for biotech development. 🚀

featured image of Astellas' Gastric Cancer Treatment Rejected by FDA Blames CDMO

Astellas’ Gastric Cancer Treatment Rejected by FDA Blames CDMO

BIOT

📢 Astellas' gastric cancer antibody rejected by FDA due to CDMO issues. Setback for treatment, importance of reliable CDMO highlighted. 😞🔍🏭📉💡

featured image of Supercharge Vaccine Development with Automation and Collaboration

Supercharge Vaccine Development with Automation and Collaboration

BIOT

🧪 Recombinant protein vaccines are safe, effective, and easy to store, making them a leading human vaccine technology. ⏰ Shortening the time from vaccine discovery to commercialization is crucial for better pandemic preparedness. 🤖 Automation and digitalization can speed up vaccine development. 👥 Collaboration and open access platforms can facilitate knowledge sharing and ensure global access to vaccines. 💪 Scalable biotech manufacturing facilities with modular and flexible technologies are essential for large-scale production. 🏭 CDMOs have become crucial in responding to vaccine production demands. 🌍 Ensuring stable supply chains and timely regulatory certifications is necessary for CDMOs.

featured image of Game-changing Solution: Abundant Albumin Opens Doors

Game-changing Solution: Abundant Albumin Opens Doors

BIOT

📅 December 20, 2023: Abundant albumin offers opportunities for CDMOs! 🧪💼 Break the monopoly, reduce costs, and increase product likelihood! 🚀🔬